Author

Jean‐Maurice Dumont

Observed name: Jean-Maurice Dumont

Institution: Debiopharm (Switzerland)

Observed institution: Debiopharm (Switzerland)

OpenAlex ID: A5111693428

The non‐immunosuppressive cyclosporin DEBIO‐025 is a potent inhibitor of hepatitis C virus replication in vitro†

2006 · Jan Paeshuyse, Artur Kaul, et al. · Hepatology · 279

The cyclophilin inhibitor Debio-025 shows potent anti–hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus

2008 · Robert Flisiak, Andrzej Horban, et al. · Hepatology · 226

Inhibition of mitochondrial permeability transition improves functional recovery and reduces mortality following acute myocardial infarction in mice

2007 · Ludovic Gomez, Hélène Thibault, et al. · American Journal of Physiology-Heart and Circulatory Physiology · 199

The Nonimmunosuppressive Cyclosporin Analogs NIM811 and UNIL025 Display Nanomolar Potencies on Permeability Transition in Brain-Derived Mitochondria

2004 · Magnus J. Hansson, Gustav Mattiasson, et al. · Journal of Bioenergetics and Biomembranes · 141

Debio 025, a Cyclophilin Binding Molecule, Is Highly Efficient in Clearing Hepatitis C Virus (HCV) Replicon-Containing Cells When Used Alone or in Combination with Specifically Targeted Antiviral Therapy for HCV (STAT-C) Inhibitors

2008 · Lotte Coelmont, Suzanne Kaptein, et al. · Antimicrobial Agents and Chemotherapy · 126

Inhibition of Human Immunodeficiency Virus Type 1 Replication in Human Cells by Debio-025, a Novel Cyclophilin Binding Agent

2008 · Roger G. Ptak, Philippe A. Gallay, et al. · Antimicrobial Agents and Chemotherapy · 112

Evaluation of a cyclophilin inhibitor in hepatitis C virus–infected chimeric mice in vivo†

2007 · Kazuaki Inoue, Takuya Umehara, et al. · Hepatology · 95

Naturally Occurring Capsid Substitutions Render HIV-1 Cyclophilin A Independent in Human Cells and TRIM-cyclophilin-resistant in Owl Monkey Cells

2005 · Udayan Chatterji, Michael D. Bobardt, et al. · Journal of Biological Chemistry · 71

Cyclophilin inhibitors in hepatitis C viral infection

2007 · Robert Flisiak, Jean-Maurice Dumont, et al. · Expert Opinion on Investigational Drugs · 44

An evaluation of the cyclophilin inhibitor Debio 025 and its potential as a treatment for chronic hepatitis C

2008 · Raf Crabbé, Grégoire Vuagniaux, et al. · Expert Opinion on Investigational Drugs · 37

Cyclosporine Increases Human Immunodeficiency Virus Type 1 Vector Transduction of Primary Mouse Cells

2006 · Josh A. Noser, Greg J. Towers, et al. · Journal of Virology · 36

Effect of cholesterol reduction by simvastatin on progression of coronary atherosclerosis: Design, baseline characteristics, and progress of the Multicenter Anti-Atheroma Study (MAAS)

1993 · Jean-Maurice Dumont · Controlled Clinical Trials · 26

Debio-025 inhibits HIV-1 by interfering with an early event in the replication cycle

2009 · Dirk Daelemans, Jean-Maurice Dumont, et al. · Antiviral Research · 21

Correlation of Naturally Occurring HIV-1 Resistance to DEB025 with Capsid Amino Acid Polymorphisms

2013 · Philippe Gallay, Roger Ptak, et al. · Viruses · 15

Vapreotide, a long-acting somatostatin analogue, dose-dependently inhibits exocrine pancreatic secretion in healthy volunteers

2000 · Pius Hildebrand, Gayathri Nair, et al. · Gastroenterology · 2

Cyclophilin Inhibitors

2011 · Grégoire Vuagniaux, Arnaud Hamel, et al. · Methods and principles in medicinal chemistry · 1

Development of near full-genome HCV1b resistance test

2007 · Sonia Van Dooren, Barbara Hendrickx, et al.

Effect of turpentine treatment on hemorheological parameters in rats

1991 · Jacques Roux, Jean-Maurice Dumont, et al. · Clinical Hemorheology and Microcirculation

Works count: 18

Citation count: 1,431

H-index: 14

I10-index: 14